Yeong Hak Bang

5PUBLICATIONS
37CO-AUTHORS
Molecular targetsPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Oct 31, 2025
Artificial intelligence-powered spatial analysis of tumor microenvironment in patients with non-small cell lung cancer with acquired resistance to EGFR tyrosine kinase inhibitor.

Yeong Hak Bang, Geun-Ho Park, Jin Woo Oh

|Mar 03, 2025
Blood TCTP as a potential biomarker associated with immunosuppressive features and poor clinical outcomes in metastatic gastric cancer.

Hyung-Don Kim, Seyoung Jung, Yeong Hak Bang

|Aug 16, 2024
Artificial Intelligence-Powered Spatial Analysis of Tumor-Infiltrating Lymphocytes as a Potential Biomarker for Immune Checkpoint Inhibitors in Patients with Biliary Tract Cancer.

Yeong Hak Bang, Choong-Kun Lee, Kyunghye Bang

|Jun 09, 2022
Clinical outcomes and prognostic factors for patients with high-risk gastrointestinal stromal tumors treated with 3-year adjuvant imatinib.

Yeong Hak Bang, Min-Hee Ryu, Hyung-Don Kim

|May 23, 2022
Real-world efficacy and safety of cabozantinib in Korean patients with advanced hepatocellular carcinoma: a multicenter retrospective analysis.

Yeong Hak Bang, Choong-Kun Lee, Changhoon Yoo

Pageof 1

Frequent Collaborators

3 joint publications

Changhoon Yoo

2 joint publications

Hyung-Don Kim

1 joint publications

Hong Jae Chon

1 joint publications

Choong-Kun Lee